Search Results for keywords:"Grant Applications"

The National Cancer Institute has announced upcoming meetings focused on reviewing and evaluating grant applications, set to take place virtually on April 10-11, 2025. These meetings will be closed to the public to protect confidential information and personal privacy. They involve the National Cancer Institute Special Emphasis Panel, which aims to explore innovative technologies for cancer research. Interested parties can contact Jeffrey E. DeClue, the Scientific Review Officer, for further information.

The Centers for Disease Control and Prevention (CDC) has announced a closed meeting for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) scheduled for April 1-2, 2025. The meeting will be held via web conference and is closed to the public to protect confidential information. It will focus on reviewing and evaluating grant applications related to formative research and pilot-testing aimed at preventing intimate partner violence and sexual violence. For more details, contact Carlisha Gentles at the CDC.

The National Heart, Lung, and Blood Institute announced a closed meeting for the Heart, Lung, and Blood Initial Review Group's NHLBI Single-Site and Pilot Clinical Trials Study Section. This meeting is scheduled for February 26-27, 2025, from 9:00 a.m. to 6:00 p.m. and will be held virtually. It is intended to review and evaluate grant applications but will be closed to the public to protect sensitive information and personal privacy. The contact person for the meeting is Dr. YingYing Li-Smerin, who can be reached via email.

The Center for Scientific Review at the National Institutes of Health has announced several upcoming closed meetings. These meetings, held virtually, are scheduled for April 22-23 and April 30-May 1, 2025, and will focus on reviewing and evaluating grant applications related to infectious diseases and immunology. The meetings will remain closed to protect sensitive information, including trade secrets and personal details associated with the grant applications. The Federal Advisory Committee Act guidelines are followed to ensure confidentiality.

The Agency for Healthcare Research and Quality (AHRQ) will hold a Special Emphasis Panel (SEP) meeting on January 10, 2025, focused on implementing and evaluating patient-centered clinical decision support strategies in real-world settings. This meeting, which will review grant applications, is closed to the public because it may involve confidential information. The discussions could involve trade secrets or private information that cannot be shared publicly to avoid privacy violations. The meeting will take place via video review at their location in Rockville, Maryland.

The National Eye Institute announced that a meeting will take place on February 2, 2021, for reviewing and evaluating grant applications as part of the BRAIN Initiative. The meeting will be closed to the public to protect confidential trade secrets and personal information pertaining to the grant applications. Participants will connect virtually, and the session will run from 12:00 p.m. to 3:30 p.m. Dr. Brian Hoshaw, a representative from the National Institutes of Health, can be contacted for more information regarding the meeting.

The National Center for Advancing Translational Sciences will hold closed meetings to review grant applications for a special panel on April 3, 2025. The meetings are closed to the public to protect confidential business information and personal privacy. They will be held virtually from 10:30 a.m. to 3:00 p.m. The review process will be overseen by Ming Yan, Ph.D., at the National Institutes of Health in Bethesda, Maryland.

Notice has been given for a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel on February 24-25, 2025. The Centers for Disease Control and Prevention (CDC) will use a video-assisted format to review grant applications related to Occupational Safety and Health Education and Research Centers. The meeting will remain private to protect trade secrets and personal information. Concerns or inquiries can be directed to Dr. Michael Goldcamp, the Scientific Review Officer at the CDC.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting scheduled for May 5, 2021. The meeting concerns the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, specifically focusing on a project titled "Feasibility of a Model Cancer Screening Surveillance Report Using All-Payer Claims Data." It will take place via teleconference from 11:00 a.m. to 6:00 p.m. EDT and is closed to the public to protect confidential information and personal privacy associated with grant applications. For more information, individuals can contact Jaya Raman, Ph.D., the Scientific Review Officer at the CDC.

The Centers for Disease Control and Prevention (CDC) are holding a meeting on May 4, 2021, by teleconference to review grant applications related to sun safety among outdoor workers. This meeting is closed to the public to protect confidential information and personal privacy. The Director of the CDC's Strategic Business Initiatives Unit has the authority to issue notices about such meetings. For more information, Jaya Raman, Ph.D., is the contact person at the CDC.